By combining semaglutide and cagrilintide, were seeing superior outcomes in both blood glucose control and weight reduction beyond those achieved with each therapy individually, said Martin Holst Lange, executive vice president, chief scientific officer, and head of Research and Development at Novo Nordisk in the companys official announcement
Semaglutide is a proven, FDA-approved GLP-1 agonist for weight loss (1520% body weight reduction in clinical trials) Tirzepatide is a dual GIP/GLP-1 agonist showing up to 22% weight loss in trials often more potent than Semaglutide for some patients Retatrutide is an experimental triple agonist with promising early results, but is NOT FDA-approved and not yet available at Better Med Spa All three require medical supervision, lifestyle changes, and ongoing monitoring for safe, sustainable results Better Med Spa in Lincoln Park currently offers Semaglutide and Tirzepatide with physician-directed protocols, slow titration, and holistic wellness integration Quick Comparison: Semaglutide vs
The additional receptors in retatrutide increase metabolic rate, enhance fat breakdown, and reduce nausea while providing the same appetite suppression and gastric slowing as Ozempic
Molecules.
We hope this gives some insight into the problematic nature of pinpointing cause and effect within the constraints of such a complex environment
